Flash Finance

Lactose India Ltd524202Corporate

Pharmaceuticals Latest results: Jun 2026 14 quarters of data
₹99.35
MCap ₹129 Cr · P/E 18.6
Lactose India Ltd — Stock analysis & AI research Lactose India Ltd — Live exchange announcements
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹47 Cr
Sales · Jun 2026
+18.7% YoY
₹6 Cr
Operating Profit · Jun 2026
+35.9% YoY
12.9%
OPM % · Jun 2026
+14.2% YoY
₹2 Cr
Net Profit · Jun 2026
+57.7% YoY
₹1.88
EPS · Jun 2026
+58.0% YoY

📝 Lactose India Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Lactose India Ltd reported revenue of ₹47 crore for the quarter ended June 2026 (Q1 FY27), up 18.7% from ₹40 crore in the same quarter last year, and up 2.6% sequentially over the March 2026 quarter.

Net profit rose 57.7% year-on-year to ₹2 crore, from ₹2 crore. Earnings per share (EPS) came in at ₹1.88.

Operating profit stood at ₹6 crore — an operating margin (OPM) of 12.9%, compared with 11.3% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Lactose India Ltd posted revenue of ₹163 crore, a growth of 40.3% over FY25, with a net profit of ₹6 crore (up 17.6% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹171 crore with a net profit of ₹7 crore.

Valuation snapshot

At the current price of ₹99.35, 524202 has a market capitalisation of ₹129 crore and a trailing P/E of about 18.6.

Within the Pharmaceuticals industry, it is the 25th-largest of the 82 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 53.65%, domestic institutional investors (DIIs) 0.62%, public shareholders 45.74% of Lactose India Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹129 Cr
Current Price ?
₹99.3
P/E ?
18.62below ind
Industry P/E ?
22.40
P/B ?
1.99
P/S ?
0.76
P/FCF ?
-25.83
Enterprise Value ?
₹191 Cr
EV/EBITDA ?
9.85
PEG ?
0.26
Earnings Yield ?
7.0%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹171 Cr
OPM ?
11.4%
Profit after tax (TTM) ?
₹7 Cr
EPS (TTM) ?
₹5.34
ROCE ?
11.0%
ROE ?
10.7%
ROA ?
3.8%
Growth
Sales — latest qtr ?
₹47 Cr
PAT — latest qtr ?
₹2 Cr
YoY qtr sales growth ?
18.7%
YoY qtr profit growth ?
57.7%
Sales growth (3y) ?
35%
Sales growth (5y) ?
36%
Profit growth (3y) ?
72%
Profit growth (5y) ?
35%
Financial Health
Debt ?
₹62 Cr
Debt to Equity ?
0.95
Interest Coverage ?
2.4
Current Ratio ?
N/A
Ownership
Promoter holding ?
53.65%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
-7.1%
Return 6 months ?
15.4%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 2627243329293029284041374647 +18.7% +2.6%
Operating Profit 44366653345356 +35.9% +21.0%
Other Income 00000001000101 +36.5% +154.5%
Interest 22111112211112 +44.6% +23.4%
Depreciation 11112111111122 +19.5% +9.2%
Profit Before Tax 11144331123123 +41.2% +40.0%
Net Profit 11132220122122 +57.7% +25.8%
EPS 0.710.760.642.091.911.801.610.170.511.191.720.421.491.88 +58.0% +26.2%
OPM % 15.4% 13.7% 13.9% 17.5% 20.8% 18.9% 16.5% 10.3% 12.3% 11.3% 12.8% 8.3% 11.0% 12.9% +14.2% +17.3%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹116 Cr ₹163 Cr ₹171 Cr +40.3%
Operating Profit ₹17 Cr ₹18 Cr ₹19 Cr +4.9%
OPM % 14.58% 10.91% 11.37% -25.2%
NPM % 4.43% 3.72% 4.06% -16.0%
Other Income ₹1 Cr ₹2 Cr ₹2 Cr +12.4%
Depreciation ₹5 Cr ₹6 Cr ₹6 Cr +6.7%
Interest ₹6 Cr ₹5 Cr ₹6 Cr -16.9%
EBIT ₹12 Cr ₹12 Cr ₹13 Cr +4.1%
PBT ₹7 Cr ₹9 Cr ₹10 Cr +24.4%
Tax — — ₹1 Cr —
Net Profit ₹5 Cr ₹6 Cr ₹7 Cr +17.6%
EPS ₹4.09 ₹4.82 ₹5.51 +17.8%
Material Cost — — ₹32 Cr —
Employee Cost — — ₹4 Cr —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
CWIP 00100 -100.0%
Equity Capital 13131313 +0.0%
Reserves 28354652 +13.0%
Borrowings 38395762 +8.8%
Other Liabilities 22141856 +211.1%
Total Liabilities 101101133183 +37.6%
Fixed Assets 56555269 +32.7%
Investments 0000 —
Other Assets 454671114 +60.6%
Total Assets 101101133183 +37.6%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 89-06 —
Cash from Investing Activity -1-2-16-10 +37.5%
Cash from Financing Activity -8-6191 -94.7%
Net Cash Flow -113-4 -233.3%
Free Cash Flow 67-14-5 +64.3%
CFO/OP 70%50%5%37% +640.0%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
ROCE % 9%18%13%11% -15.4%
Debtor Days 69496875 +10.3%
Inventory Days 344119171217 +26.9%
Days Payable 2755974146 +97.3%
Cash Conversion Cycle 138109165146 -11.5%
Working Capital Days 56262418 -25.0%

👥 Shareholding (latest 4 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026 % Chg
Promoters 53.65%53.65%53.65%53.65% +0.0%
DIIs 0.62%0.62%0.62%0.62% +0.0%
Public 45.73%45.73%45.73%45.74% +0.0%
No. of Shareholders 17,01316,81016,77016,670 -0.6%

⚖️ Peer comparison

Industry: Pharmaceuticals · top 25 of 82 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 SUDEEPPHRM Sudeep Pharma ₹1,033.30 11,671 63.3 675 184 34.6% 27.3% — — 26.6% 30.9%
2 SPARC Sun Pharma ₹185.08 6,006 3.8 1,909 1,584 84.7% 83.0% 2512.3% 553.9% 314.1% 59.9%
3 GUJTHEM Gujarat Themis ₹412.60 5,370 92.3 173 48 47.3% 27.8% 8.6% -6.1% 21.6% 23.0%
4 539997 Kwality Pharmaceuticals ₹2,652.10 3,525 34.0 553 81 24.4% 14.6% 35.7% 71.8% 46.3% 113.5%
5 524632 Shukra Pharmaceuticals ₹80.95 2,403 99.9 75 36 65.0% 48.2% 74.0% 130.1% 336.4% 1359.2%
6 FERMENTA Fermenta Biotech ₹475.00 1,362 21.4 501 64 18.9% 12.7% — — -17.9% -30.6%
7 506414 Fermenta Biotech ₹552.60 1,313 27.2 511 59 17.6% 11.5% 11.9% -6.6% -10.4% -56.7%
8 AHCL Anlon Healthcare ₹20.20 1,074 — — — — — — — 163.0% 133.3%
9 541096 Bharat Parenterals ₹1,525.00 1,062 — 323 -30 3.3% -9.3% 1.5% 37.5% -19.2% -309.6%
10 540737 Shree Ganesh ₹796.30 855 66.2 99 15 31.4% 15.6% 0.7% -23.0% -41.8% -67.5%
11 AMANTA Amanta Healthcare ₹197.75 768 52.5 291 15 20.4% 5.0% — — 5.4% -5.6%
12 539730 Fredun Pharmaceuticals ₹827.85 611 10.3 747 44 14.7% 5.9% 40.1% 90.0% 90.2% 88.1%
13 500422 Transchem Ltd-$ ₹38.00 474 10.8 — 4 — — -100.0% -17.8% -100.0% 186.3%
14 HALEOSLABS Haleos Labs ₹1,525.00 461 21.0 324 15 12.6% 4.7% -3.2% -4.9% -11.6% -58.0%
15 524731 Jenburkt Pharmaceuticals ₹865.75 404 11.6 170 33 23.6% 19.4% 11.8% 6.1% -1.4% -26.4%
16 543616 Trident Lifeline ₹279.85 364 14.0 134 24 24.6% 17.9% — — 42.6% 44.2%
17 512600 Astal Laboratories ₹75.00 308 32.3 170 10 8.8% 5.7% 142.9% -9.0% 56.0% 77.4%
18 524828 BDH Industries ₹336.80 300 16.6 100 12 15.3% 11.7% 44.3% 16.6% 20.2% 48.8%
19 500009 Ambalal Sarabhai ₹38.73 297 21.9 206 14 7.1% 6.6% 3.1% 261.1% 8.0% -51.6%
20 532039 Zenotech Laboratories ₹64.90 263 — 45 -3 17.0% -5.6% 1.3% -119.2% 10.1% -146.0%
21 531739 Gennex Laboratories ₹13.87 255 19.0 183 21 14.4% 11.3% 24.9% 15.5% 16.6% -6.9%
22 524790 Everest Organics ₹159.20 252 29.4 191 5 10.3% 2.8% 23.0% 527.7% -10.0% -21.1%
23 530163 Kerala Ayurveda ₹310.20 225 — 125 -26 -14.9% -20.8% 9.0% -16.8% -21.3% -477.8%
24 531569 Sanjivani Paranteral ₹199.95 214 32.7 66 7 15.3% 11.3% -7.6% -14.4% 8.8% 32.7%
25 524202 Lactose India ₹172.70 129 31.3 171 7 11.4% 4.1% 40.3% 17.6% 18.7% 57.7%
❓ Frequently asked questions
What was Lactose India Ltd's revenue in Q1 FY27?
Lactose India Ltd reported revenue of ₹47 crore for the quarter ended June 2026 (Q1 FY27), up 18.7% from ₹40 crore in the same quarter last year, and up 2.6% sequentially over the March 2026 quarter.
What was Lactose India Ltd's net profit in Q1 FY27?
Net profit rose 57.7% year-on-year to ₹2 crore, from ₹2 crore. Earnings per share (EPS) came in at ₹1.88.
What is 524202's market capitalisation and P/E ratio?
At the current price of ₹99.35, 524202 has a market capitalisation of ₹129 crore and a trailing P/E of about 18.6.
Who owns Lactose India Ltd? (shareholding pattern)
As of Mar 2026, promoters held 53.65%, domestic institutional investors (DIIs) 0.62%, public shareholders 45.74% of Lactose India Ltd.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI